Annovis Bio Inc.

NYSE: ANVS · Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT

Annovis Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-24.59B -56.2M -25.33M -14.49M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
3.84B 4.63M 9.15M 4.7M
Other Working Capital
-331.43K 2.44M -4.41M 311.13K
Other Non-Cash Items
-1.14B 11.84M n/a n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
681.71K -228.6K -1.14M 657.35K
Operating Cash Flow
-21.89B -39.97M -17.31M -9.13M
Capital Expenditures
4.00 4.00 4.00 n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
26.67B 458.38K n/a 95.1K
Financial Cash Flow
26.69B 17.34M 4.61K 46.74M
Net Cash Flow
4.8B -22.62M -17.31M 37.61M
Free Cash Flow
-21.89B -39.97M -17.31M -9.13M